Fasting reduces tear production

Article

Fasting significantly reduces the amount of tears produced by the eye and increases the osmolarity of the tears, according to new research.

Fasting significantly reduces the amount of tears produced by the eye and increases the osmolarity of the tears, according to new research published in Eye & Contact Lens: Science & Clinical Practice. Fasting does not deteriorate the parameters of corneal topography or ocular aberrations in people who are healthy, however.

The study authors conducted a prospective controlled study of 29 eyes in 29 healthy men (mean age, 27.8 ± 5.9 years; range, 20 to 47 years). All of the men underwent corneal topography via a placido disc corneal topography and aberrometry device (OPD-Scan II, Nidek) before their ophthalmic examinations. Researchers used an osmometer (OcuSense, Tear Lab) to measure tear osmolarity. They also evaluated ocular surface disease index (OSDI) scores, tear break-up time (BUT), Schirmer I test and lissamine green staining.

The investigators took measurements between 4 pm and 5 pm before and during Ramadan and compared them using paired sample t test, considering a P value of less than 0.05 as statistically significant.

The researchers found:

  • The mean tear osmolarity values were 285.6 ± 8.2 mOsm/L in nonfasting periods and 293.3 ± 16.0 mOsm/L in fasting periods.
  • The mean Schirmer I values were 14.8 ± 6.0 mm in nonfasting periods and 10.6 ± 5.3 mm in fasting periods.
  • Tear osmolarity, OSDI and Oxford grading scores significantly increased during the fasting period compared with the nonfasting period.
  • Schirmer I values and IOP decreased during the fasting period compared with the nonfasting period.
  • No significant differences occurred in tear BUT, keratometry values and corneal aberration measurements in nonfasting periods compared with fasting periods.

To read an abstract of the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.